An observational study in Long QT Syndrome and Channelopathies, sponsored by University of Sao Paulo. Not yet recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by University of Sao Paulo · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Patients with congenital long QT syndrome (LQTS) have traditionally been discouraged from physical activity and competitive sports, although the rate of exercise-related arrhythmic events is considered low. In recent years, international guidelines have become less restrictive and now support shared decision-making between physicians, patients and families to promote safe physical activity. Excessive restriction, especially in young people, may negatively affect mental health, quality of life and overall cardiovascular risk. However, little is known about the physical activity level and physical fitness of patients with LQTS in clinical practice.
This observational study will describe the baseline functional capacity, physical activity level and quality of life of adults with congenital LQTS followed at the Arrhythmia Outpatient Clinic of the Heart Institute (InCor), São Paulo, Brazil, and compare them with patients with arrhythmias and a structurally normal heart. Participants will answer questionnaires on physical activity, quality of life and barriers to exercise, and will undergo cardiopulmonary exercise testing and 24-hour Holter monitoring. This is the first step of the Channelopathies Movement and Exercise Study (CANMOVE).
Background
Congenital long QT syndrome (LQTS) is a genetically determined channelopathy characterized by delayed ventricular repolarization, which may cause syncope, ventricular arrhythmias and sudden cardiac death. The three most frequent subtypes, associated with variants in KCNQ1 (LQT1), KCNH2 (LQT2) and SCN5A (LQT3), account for about 90% of genotype-positive cases and have specific arrhythmic triggers: exercise in LQT1, auditory stimuli in LQT2 and rest in LQT3.
Patients with LQTS have historically been advised against most sports. Recent American and European recommendations are less restrictive and favor shared decision-making, especially in asymptomatic genotype-positive, phenotype-negative individuals. Registry data suggest a low rate of sport-related events in athletes with LQTS who remain active under appropriate management, including beta-blocker therapy. On the other hand, children with LQTS have shown lower peak oxygen consumption and ventilatory anaerobic threshold than healthy controls, possibly due to beta-blocker-induced chronotropic limitation and deconditioning. There are no data on the physical activity profile and functional capacity of patients with LQTS followed in Brazilian clinical practice.
The Channelopathies Movement and Exercise Study (CANMOVE) is a broader initiative to analyze physical activity in patients with cardiac channelopathies. This project is its first step, focused on congenital LQTS.
Study design
Single-center observational study at the Heart Institute (Instituto do Coração, InCor), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, Brazil. The study combines a historical cohort, with physical activity data partially obtained from a previously approved study on physical activity in patients with cardiac arrhythmias (SDC 5310/21/085), and prospective inclusion of new patients with LQTS during the study period. The control group will consist of patients with cardiac arrhythmias and a structurally normal heart already included in the previous study, selected by propensity score matching.
Procedures
All prospective participants will undergo CPET and 24-hour Holter monitoring using a standardized protocol for patients with LQTS. Beta-blocker therapy and other treatments (antiarrhythmic drugs, implantable cardioverter-defibrillator [ICD], sympathectomy) will be recorded. Data will be collected from electronic medical records and stored in the Research Electronic Data Capture (REDCap) platform.
Statistical analysis
Approximately 60 patients with congenital LQTS are expected. Categorical variables will be presented as absolute and relative frequencies, and continuous variables as mean and standard deviation or median and interquartile range. Patients with LQTS will be compared with controls matched by propensity score, calculated by logistic regression. Associations between categorical variables will be assessed by chi-square or Fisher's exact test, and continuous variables will be compared by Student's t test or Mann-Whitney test, according to distribution. P values below 0.05 will be considered statistically significant.
101 studies on the registry are indexed under Long QT Syndrome; 20 are open to participants now.
This study's planned enrollment of 120 is below the median of 150 across 53 observational studies indexed under Long QT Syndrome.
Browse Long QT Syndrome studies →University of Sao Paulo is the lead sponsor of 1,036 studies on the registry; 96 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Adults with congenital long QT syndrome followed at the Arrhythmia Outpatient Clinic of the Heart Institute (InCor), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, Brazil. Controls are patients with cardiac arrhythmias and a structurally normal heart from the same institution.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
On an ECG, the QT interval is the time the heart’s lower chambers take to activate electrically and recover in each beat. QTc is that time adjusted for heart rate (QTcF by Fridericia’s formula, QTcB by Bazett’s). Some medicines lengthen it, and a long QTc can raise the risk of a dangerous heart rhythm.
The study may name a correction formula and a limit in milliseconds, often around 450–480.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.
Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.
QT and QTc
On an ECG, the QT interval is the time the heart’s lower chambers take to activate electrically and recover in each beat. QTc is that time adjusted for heart rate (QTcF by Fridericia’s formula, QTcB by Bazett’s). Some medicines lengthen it, and a long QTc can raise the risk of a dangerous heart rhythm.
The study may name a correction formula and a limit in milliseconds, often around 450–480.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ECOG performance status
A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.
Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adults with a confirmed diagnosis of congenital long QT syndrome (LQTS) by clinical and/or genetic criteria, followed at the Arrhythmia Outpatient Clinic of the Heart Institute (InCor).
Other: Questionnaires · Diagnostic Test: Cardiopulmonary exercise testing · Diagnostic Test: 24-hour Holter monitoring
Patients with cardiac arrhythmias and a structurally normal heart from a previous study on physical activity in patients with cardiac arrhythmias, selected by propensity score matching.
Other: Questionnaires · Diagnostic Test: Cardiopulmonary exercise testing · Diagnostic Test: 24-hour Holter monitoring
International Physical Activity Questionnaire short form (IPAQ), 12-Item Short Form Health Survey (SF-12) and structured questionnaire on daily life and barriers to physical activity.
Treadmill ramp protocol with continuous metabolic, ventilatory and 12-lead electrocardiogram monitoring until exhaustion.
Continuous 3-channel electrocardiogram recording for 24 hours.
Peak oxygen consumption (VO2 peak)
Baseline functional capacity measured as peak oxygen consumption (mL/kg/min) on cardiopulmonary exercise testing.
Time frame: At baseline (single assessment)
Physical activity level
Weekly time spent walking and in moderate and vigorous physical activity, measured by the International Physical Activity Questionnaire short form (IPAQ).
Time frame: At baseline (single assessment)
Quality of life Questionnaire
Physical and mental component scores of the 12-Item Short Form Health Survey (SF-12). Scores range from 0 to 100, with higher scores indicating better health-related quality of life.
Time frame: At baseline
Proportion of patients who wish to engage in physical exercise
Proportion of participants answering yes to the question on willingness to practice physical exercise in the structured daily life questionnaire.
Time frame: At baseline
Reasons for not practicing physical exercise
Frequency of each reported reason for not exercising (medical advice, dislike, lack of time, arrhythmia diagnosis, defibrillator shock, device implantation) in the structured daily life questionnaire.
Time frame: At baseline
Association between physical activity level and arrhythmias
Association between physical activity level measured by the International Physical Activity Questionnaire (IPAQ) and the type and frequency of arrhythmias detected on 24-hour Holter monitoring and cardiopulmonary exercise testing.
Time frame: At baseline
Heart rate variability
Time-domain heart rate variability indices measured on 24-hour Holter monitoring.
Time frame: At baseline
Corrected QT interval during exercise and recovery
Corrected QT interval (QTc, ms) at rest (supine and standing), at peak exercise and during recovery on cardiopulmonary exercise testing.
Time frame: At baseline
Start is estimated for Nov 2026; primary completion for Nov 2028, 24 months later.
Of 21 observational studies under Long QT Syndrome, half reached primary completion within 56 months of starting (the median), counting those still running; a quarter within 26 and three quarters within 81. This study's planned 24 months is below that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.